MC
Merck & Co Portfolio holdings
AUM
$216M
1 Year Est. Return
–
AUM
$216M
AUM Growth
+$51.3M
(+31%)
Holding
13
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Personalis
PSNL
$855M
| $92.1M | 42.73% |
14,044,943
|
|
||
2
Moderna
MRNA
$10.6B
| $63.7M | 29.54% |
2,308,190
|
|
||
3
Kymera Therapeutics
KYMR
$4.42B
| $33.7M | 15.63% |
772,165
|
|
||
4
Entrada Therapeutics
TRDA
$264M
| $11.7M | 5.42% |
1,739,768
|
|
||
5
Alector
ALEC
$149M
| $4.96M | 2.3% |
3,545,719
|
|
||
|
EVAX
6
Evaxion A/S
EVAX
$45.6M
| $2.97M | 1.38% |
1,214,126
|
|
||
7
Sutro Biopharma
STRO
$94.9M
| $1.94M | 0.9% |
2,723,509
|
|
||
8
LAVA Therapeutics
LVTX
$42.9M
| $1.52M | 0.7% |
1,149,345
|
|
||
9
Viridian Therapeutics
VRDN
$2.2B
| $1.31M | 0.61% |
93,414
|
|
||
10
Xilio Therapeutics
XLO
$41.3M
| $1.01M | 0.47% |
1,483,758
|
|
||
|
CARM
11
DELISTED
Carisma Therapeutics
CARM
| $577K | 0.27% |
1,473,240
|
|
||
|
NEUP
12
Neuphoria Therapeutics
NEUP
$10.7M
| $71.2K | 0.03% |
10,027
|
|
||
|
HURA
13
TuHURA Biosciences
HURA
$130M
| $31.1K | 0.01% |
+13,950
|
|